$1.42 -0.04 (-2.74%)
11/30/2009 1:18 PM

AVI BioPharma, Inc. (AVII)

CAPS Rating: 4 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Featured Broker Partners